
    
      The purpose of this study is to assess the speed of absorption of BIOD-238 and BIOD-250
      compared to Humalog®. Secondary objectives are to assess other pharmacokinetic
      characteristics of BIOD-238 and BIOD-250 compared to Humalog®, and to evaluate the safety and
      tolerability of BIOD-238 and BIOD-250 compared to Humalog®.
    
  